Chemistry & Biochemistry Seminar: "Modern Nanotechnologies for the Treatment of Cancer and Infectious Diseases"

By: Dr. Santimukul Santra, Missouri State University

Abstract

Our lab research focuses on investigating new nanotechnologies for helping society with cancer and infectious diseases. We develop high throughput, bioinspired nanoplatforms for delivering anticancer therapeutics and antivirals, while creating novel catalytic nanolabels for assessment of protective immunity of vaccination; and point-of-care (PoC) technologies for the detection of infectious diseases. This presentation will introduce at our smart design for dendritic biomaterials and responsive nanoplatforms for targeted delivery for cancer therapeutics and for the SARS-CoV-2 vaccine formulations. This vaccine delivery platform offers unique features of carrying large protecting mRNA payloads and nuclei acids deliverables. In addition, the unique catalytic nanosensors labels’ were integrated with lateral flow assay (LFA) technology for assessing COVID-19 vaccine immunity that allows visualization of test results and for the detection of foodborne pathogens. The development of such modern nanotechnology platforms and their applications in biomedical research will be highlighted in this presentation. 

Free